Hospitals

Magellan Robotic System

Electrophysiology Robotics Program

Atrial fibrillation, the most common type of cardiac arrhythmia, affects approximately 3 million Americans today. That number is expected to grow to 12 million by 2050.1 Treatment options include medication, life style changes, and surgical options such as catheter ablation. Multiple studies have demonstrated that catheter ablation is a viable treatment option for atrial fibrillation patients.2

With the growing prevalence of atrial fibrillation, hospitals with electrophysiology and cardiac arrhythmia programs will likely experience growing demand for atrial fibrillation treatments. Implementation of the Sensei X Robotic System has the potential to improve patient through- put through procedural efficiency, predictability, and cath lab utilization.3

 

SEE HOW ONE HOSPITAL INCREASED DAILY CATH LAB CAPACITY WITH THE IMPLEMENTATION OF A ROBOTICS PROGRAM

  1. Atrial Fibrillation Fact Sheet, CDC, Feb. 2010
  2. Calkins, H. et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. HRS 2012
  3. Kaiser, C.P. Texas Health Arlington Memorial Hospital Becoming a Center of Excellence. Cardiovascular Business 2011.